"Our goal is to provide customers with "best in class" development services which accelerate customer molecules to market efficiently. We will continue to add new technologies and value-added services to meet the development needs of our customers."

Dr. Shabbir Anik
President, Global Pharmaceutical Development Services and Chief Scientific Officer Patheon Inc.

Patheon offers customers a fully integrated and seamless approach to pharmaceutical dosage form development. Our services are dedicated to finding the most rapid and cost-effective route to move your molecule from development to commercialization. From accelerated early phase development programs, to Clinical Trial Materials (CTM) supply and scale-up Patheon offers full formulation and analytical expertise for virtually all types of molecules.

The integrated nature of our customized development programs can result in the reduced need for costly reformulations at later stages of development and offer cleaner paperwork and a clearer audit trail by using only a single service provider.

Our fully scalable and flexible services are coupled with strong scientific expertise.
Patheon delivers development services from six development centers located in Canada, Italy, the United Kingdom and the United States. See Our Sites for Virtual Tours of our development centers.